Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics

Immunotherapy has emerged as one of the most promising approaches for ovarian cancer treatment. The tumor microenvironment (TME) is a key factor to consider when stimulating antitumoral responses as it consists largely of tumor promoting immunosuppressive cell types that attenuate antitumor immunity...

Descripción completa

Detalles Bibliográficos
Autores principales: McCloskey, Curtis W., Rodriguez, Galaxia M., Galpin, Kristianne J. C., Vanderhyden, Barbara C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115831/
https://www.ncbi.nlm.nih.gov/pubmed/30049987
http://dx.doi.org/10.3390/cancers10080244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115831/
https://www.ncbi.nlm.nih.gov/pubmed/30049987
http://dx.doi.org/10.3390/cancers10080244

Ejemplares similares